Evidence map›Paper›PMID 29584914›Full record

ArticleJournal of animal science2018

Antimicrobial resistance of Enterococcus faecium strains isolated from commercial probiotic products used in cattle and swine.

Raghavendra G Amachawadi, Felicia Giok, Xiaorong Shi, Jose Soto, Sanjeev K Narayanan, Mike D Tokach, Mike D Apley, T G Nagaraja

Abstract read
In one paragraph

Article in Journal of animal science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Avian PathogenicVeterinary sciences · 2025
    Review
  2. Article
  3. Article
  4. The Effect of Orally Administered Multi-Strain Probiotic Formulation (International journal of molecular sciences · 2024
    Article
  5. Article
  6. Safety Assessment of OneFoods (Basel, Switzerland) · 2022
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Properties of a New Probiotic Candidate and Lactobacterin-TKProbiotics and antimicrobial proteins · 2020
    Article
  14. Article
  15. Horizontal transfer ofJournal of animal science and biotechnology · 2019
    Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Raghavendra G AmachawadiDepartments of Clinical Sciences, Kansas State University, Manhattan, KS.
Felicia GiokDiagnostic Medicine/Pathobiology, Kansas State University, Manhattan, KS.
Xiaorong ShiDiagnostic Medicine/Pathobiology, Kansas State University, Manhattan, KS.
Jose SotoAnimal Sciences and Industry, Kansas State University, Manhattan, KS.
Sanjeev K NarayananDiagnostic Medicine/Pathobiology, Kansas State University, Manhattan, KS.
Mike D TokachAnimal Sciences and Industry, Kansas State University, Manhattan, KS.
Mike D ApleyDepartments of Clinical Sciences, Kansas State University, Manhattan, KS.
T G NagarajaDiagnostic Medicine/Pathobiology, Kansas State University, Manhattan, KS.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Probiotics, an antibiotic alternative, are widely used as feed additives for performance benefits in cattle and swine production systems. Among bacterial species contained in probiotics, Enterococcus faecium is common. Antimicrobial resistance (AMR), particularly multidrug resistance, is a common trait among enterococci because of their propensity to acquire resistance and horizontally transfer AMR genes. Also, E. faecium is an opportunistic pathogen, and in the United States, it is the second most common nosocomial pathogen. There has been no published study on AMR and virulence potential in E. faecium contained in probiotic products used in cattle and swine in the United States. Therefore, our objectives were to determine phenotypic susceptibilities or resistance to antimicrobials, virulence genes (asa1, gelE, cylA, esp, and hyl) and assess genetic diversity of E. faecium isolated from commercial products. Twenty-two commercially available E. faecium-based probiotic products used in cattle (n = 13) and swine (n = 9) were procured and E. faecium was isolated and species confirmed. Antimicrobial susceptibility testing to determine minimum inhibitory concentrations was done by micro-broth dilution method using National Antimicrobial Resistance Monitoring Systems Gram-positive Sensititre panel plate (CMV3AGPF), and categorization of strains as susceptible or resistant was as per Clinical Laboratory and Standards Institute's guidelines. E. faecium strains from 7 products (3 for swine and 4 for cattle) were pan-susceptible to the 16 antimicrobials tested. Strains from 15 products (6 for swine and 9 for cattle) exhibited resistance to at least one antimicrobial and a high proportion of strains was resistant to lincomycin (10/22), followed by tetracycline (4/22), daptomycin (4/22), ciprofloxacin (4/22), kanamycin (3/22), and penicillin (2/22). Four strains were multidrug resistant, with resistant phenotypes ranging from 3 to 6 antimicrobials or class. None of the E. faecium strains were positive for any of the virulence genes tested. The clonal relationships among the 22 E. faecium strains were determined by pulsed-field gel electrophoresis (PFGE) typing. A total of 10 PFGE patterns were observed with 22 strains and a few of the strains from different probiotic products had identical (100% Dice similarity) PFGE patterns. In conclusion, the E. faecium strains in a few commercial probiotics exhibited AMR to medically-important antimicrobials, but none contained virulence genes.

Indexed as

Drug Resistance, BacterialProbioticsAnimalsAnti-Infective AgentsCattleCattle DiseasesElectrophoresis, Gel, Pulsed-FieldEnterococcus faeciumGenetic VariationGram-Positive Bacterial InfectionsMicrobial Sensitivity TestsOpportunistic InfectionsPhenotypeSwineSwine DiseasesVirulenceAnti-Infective Agents

Identifiers

PMID29584914
PMCPMC6093546

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.